Adaptamtx
San Sebastián, ES · 1 known investors
Adaptam Therapeutics develops antibody-based cancer immunotherapies, including antibody-drug conjugates and bispecific antibodies, that target the immunosuppressive myeloid tumor microenvironment via novel targets such as glycan-binding proteins and Siglecs. A spin-off from CIC bioGUNE, the company serves oncology patients and is developing first-in-class therapies for multiple cancer indications.
Founders & leadership
AP
Asis PalazoninCEO/CSO & Founder
Investors · 1
Frequently asked questions
- What does Adaptamtx do?
- Adaptam Therapeutics develops antibody-based cancer immunotherapies, including antibody-drug conjugates and bispecific antibodies, that target the immunosuppressive myeloid tumor microenvironment via novel targets such as glycan-binding proteins and Siglecs. A spin-off from CIC bioGUNE, the company serves oncology patients and is developing first-in-class therapies for multiple cancer indications.
- Who founded Adaptamtx?
- Adaptamtx was founded by Asis Palazon.
- Who are Adaptamtx's investors?
- Adaptamtx's investors include Criteria Bio Ventures.
- Where is Adaptamtx headquartered?
- Adaptamtx is headquartered in San Sebastián, ES.